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MOTOR SYMPTOMS OF
SCHIZOPHRENIA
Schizophrenia is typically conceived as
an illness characterized by positive, neg-
ative, and cognitive symptoms. However,
most schizophrenia patients also display
a wide range of symptoms characterized
by aberrant motor functioning. Symptoms
of schizophrenia that fit this description
are catatonic features, the motoric neu-
rological soft signs (NSS), extrapyramidal
symptoms (EPS), psychomotor slowing,
and reduced motor activity.
CATATONIA
Catatonic symptoms form a heterogeneous
group of motor, emotional, and behav-
ioral symptoms. Mostly in line with histor-
ical reports, several recent studies demon-
strate a prevalence of the catatonic fea-
tures in 5–32% of schizophrenia patients
(1, 2). Although the incidence of catatonia
in schizophrenia may have decreased some-
what, the syndrome is still highly prevalent
but often underdiagnosed (2).
NEUROLOGICAL SOFT SIGNS
Neurological soft signs are a heteroge-
neous cluster of subtle neurological signs
that are generally divided into four sub-
categories: sensory integration, primitive
reflexes, motor coordination, and sequenc-
ing of complex motor acts, the latter two
being considered “motoric” NSS (3). NSS
have been demonstrated in up to 97 and
100% of neuroleptic naive and medicated
first-episode patients, respectively (1).
PSYCHOMOTOR SLOWING
Psychomotor slowing refers to the slow-
ing of various motor processes such as
gross (e.g., gait) and fine motor (e.g., writ-
ing) movement, speech, and facial expres-
sion. Our group conducted a series of
studies in which impairments in different
aspects of psychomotor functioning were
slowed, including planning, initiation, and
execution of movements (4, 5).
Several studies assessed the amount
of motor activity by means of actig-
raphy, which consistently demonstrated
reduced motor activity levels in schizo-
phrenia patients (2, 6). This reduction in
spontaneous motor behavior was associ-
ated with negative symptom severity (7, 8).
EXTRAPYRAMIDAL SYMPTOMS
Akathisia, Parkinsonism, dyskinesia, and
dystonia are considered EPS. Although
these clinical features are most persistently
linked to antipsychotic pharmacotherapy,
there is growing consensus that the use of
antipsychotic medication is not the main
cause but a contributing factor to motor
abnormalities in schizophrenia (9). In a
systematic review (10), a median rate of 9%
of spontaneous dyskinesia and a median
rate of 17% of spontaneous Parkinsonism
was reported in antipsychotic-naive first-
episode patients, thus positioning EPS as
highly prevalent intrinsic symptoms of
schizophrenia. Spontaneous Parkinsonism
and abnormal involuntary movements are
also found at increased frequencies in unaf-
fected first degree relatives of schizophrenia
patients (11).
POSITIONING MOTOR SYMPTOMS IN
SCHIZOPHRENIA
When considering all motor symptoms,
recent research demonstrates that 40–80%
of the schizophrenic patients present with
at least one categorically defined motor
syndrome (12, 13). Moreover, these symp-
toms are associated to the patients’ social,
clinical, and functional outcome (14) and
can be differentiated from positive, neg-
ative, and cognitive symptoms (15). As a
result, it can be argued that motor deficits
deserve recognition as a fourth symptom
cluster of schizophrenia.
However,despite the increasing focus on
these motor symptom cluster, the position-
ing of the motor syndrome is hampered by
some important limitations.
First, predefined motor syndromes such
as catatonia, NSS, or EPS typically stem
from different research traditions, and are
typically investigated separately. Hence,
establishing the interrelations of the differ-
ent components of motor functioning as
well as their associations to other symp-
tom groups such as negative and cogni-
tive syndromes is limited by the fact that
studies investigating more than one motor
symptom cluster are scarce.
Second, the different psychomotor
symptom clusters are assessed with differ-
ent techniques. NSS are typically assessed
by use of a neurological evaluation, psy-
chomotor slowing is consistently gauged
by use of instrumental tasks such as a
finger tapping test or computerized writ-
ing tasks, and catatonia and EPS are
commonly appraised using clinical rating
scales. As has been demonstrated, interre-
lations between motor symptoms are con-
founded by the applied assessment tech-
nique (13).
An important artifact of the exis-
tence of parallel research lines and of
www.frontiersin.org October 2014 | Volume 5 | Article 145 | 1
s
o
u
r
c
e
:
 
ht
tp
:/
/b
or
is
.u
ni
be
.c
h/
61
14
2/
 
| 
do
wn
lo
ad
ed
: 
13
.3
.2
01
7
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Morrens et al. Beyond boundaries
the boundaries imposed by the prede-
fined symptom clusters and their assess-
ment instruments is the conceptual over-
lap between the motor syndromes. For
example, rigidity is a symptom assessed
by EPS, catatonia, and NSS rating scales.
Similarly, psychomotor slowing, clinically
recognized as bradykinesia, can also be
seen as a parkinsonian sign, or as a mild
form of stupor (16). This overlap not only
exists between the different motor syn-
dromes, but also with cognitive and neg-
ative symptomatology. Decreased sponta-
neous movement is one of the features of
the negative syndrome in schizophrenia.
Similarly, several neuropsychological tasks
that are sensitive for higher order cogni-
tive deficits (e.g., symbol digit substitution
test or trail making tasks) are often used to
assess psychomotor slowing (15).
Some may argue these predefined motor
symptom clusters have internal validity,
since several of the symptoms of these
clusters (e.g., catatonic symptoms) co-
occur and these symptom clusters tend
to respond to different treatment strate-
gies: acute catatonia responds to benzo-
diazepines or electroconvulsive treatment;
EPS rather responds to anticholinergics,
although it should be noted akathisia also
responds to benzodiazepines. Neverthe-
less, the delineation between the clus-
ters can be questioned. Much confu-
sion exists on which motor symptoms
constitute catatonia, leading to different
tools that include from only 7 up to 40
signs or symptoms. Moreover, Krüger and
colleagues (17) demonstrated that cata-
tonic presentation may vary depending
on the underlying pathology, thus chal-
lenging catatonia as a homogeneous con-
struct. Besides, as mentioned before, a
strong overlap seems to exist between these
motor syndromes, justifying a reappraisal
of motor functioning in schizophrenia
based on the deconstruction of the bar-
riers between predefined motor symptom
clusters.
Very few studies focused on the neuro-
biological underpinnings of motor deficits
in schizophrenia, although abnormalities
in both cortical (anterior cingulate cortex,
supplementary motor area, premotor cor-
tex) and subcortical (basal ganglia, thala-
mus) regions as well as brain stem and cere-
bellum have been implicated [for review,
see Ref. (2)].
Table 1 | Proposed classification of motor symptomatology in schizophrenia.
Function domain Quantitative deficits Qualitative deficits
Positioning Posturing, rigidity Catalepsy, tremor, tandem walk
deficits
Mobility Reduced gait, diminished
movements, stupor
Manneristic walk
Manipulation Fine motor slowing, reduced facial
expression
Stereotypy, mannerisms, fine motor
sequence deficits, echopraxia
Oral motor functions Reduced speech Orofacial dyskinesia, echolalia
Visual functions Gaze impersistence, staring Blepharospasms
MOTOR AND PSYCHOMOTOR
FUNCTIONS
A much more fruitful and systematic
approach may be to evaluate patients based
on the different domains of motor and
psychomotor functions. Rainforth and col-
leagues (18) classified motor functioning in
five main motor skill domains: positioning,
mobility, manipulation, oral motor func-
tions, and oculomotor control. Positioning
refers to the ability to assume and maintain
a position as well as to maintain pos-
tural control. Mobility encompasses every
action that aims at traveling from one
point to another (walking, climbing, crawl-
ing). Manipulation implies every interac-
tion with your own body (e.g., clapping
hands, scratching face, . . .) or interaction
with objects (e.g., playing tennis, drawing,
writing a phrase, . . .). Oral motor func-
tions include speech and other oral func-
tions such as drinking or eating. Finally,
visual functions mainly encompass blink-
ing and the ability to fix and orient a
gaze.
Some of these domains (e.g., position-
ing) are rather basic motor skills and do
not necessarily need higher order cogni-
tive control and may mostly be executed
unconsciously while other motor domains
(e.g., manipulation of objects) are heavily
impacted by cognitive processes involved
in the planning, initiation, execution, and
monitoring of these motor acts. Conse-
quently, the functions involved in these lat-
ter motor acts are sometimes referred to
as psychomotor functions. Several studies
have aimed at further delineating the sub-
processes involved in psychomotor func-
tioning (4, 13, 19).
These basic motor and psychomotor
functions can be affected both on a
quantitative and a qualitative level; func-
tions can be increased/reduced (quantita-
tive) but there may also be a breach with
normal motor function leading to symp-
toms characterized by behavior not seen
in healthy patients (qualitative). A paral-
lel comparison can be made with cognitive
functioning; patients display quantitative
cognitive deficits (e.g., reduced memory or
attention functioning), but also qualitative
cognitive abnormalities can emerge (e.g.,
perseveration, neologisms and, arguably,
delusional thinking).
This frame of reference allows for repo-
sitioning all motor symptoms, indepen-
dent of whether they are traditionally
recognized as catatonic symptoms, EPS,
NSS, psychomotor slowing, or diminished
motor activity (see Table 1). Note that this
table does not aim to exhaustively list all
motor symptoms.
ASSESSING MOTOR SKILLS AND
PSYCHOMOTOR FUNCTIONS
An atheoretical evaluation of motor func-
tioning in schizophrenia making use of
a more broad assessment methodology
(or combination of assessment techniques)
that address all these motor function
domains may result in a more com-
plete appraisal of motor and psychomo-
tor deficits in schizophrenia, both on the
quantitative and qualitative level. Such an
approach has the advantage of giving a gen-
eral overview of all deficits and may con-
firm or nuance the existing classification
of motor symptomatology. Their relation-
ship with and delineation from negative
and cognitive symptoms can be evaluated
more properly.
Rating scales have been developed [e.g.,
the Rogers Scale (20)] that score symptoms
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from more than one motor syndrome,
although these scales still tend to focus on
qualitative abnormalities and to a much
lesser degree on quantitative abnormalities.
As a result, they do not give a complete
overview of motor functioning. On the
other hand, test batteries evaluating gen-
eral motor functioning can be considered,
e.g., the Bruininks-Oseretsky Test of motor
proficiency (BOT-2) or the movement
assessment battery for children (Move-
ment ABC-2). Typically, these batteries
aim to provide a comprehensive view on
ones motor functioning an even gener-
ate a motor quotient, a motor equivalent
of the intelligence quotient (IQ). Included
tests typically assess fine and gross motor
functions such as (static and dynamic) bal-
ance and precision, walking speed, force,
bilateral coordination, or visuomotor con-
trol (21). Since motor skills traditionally
have been viewed in relation to the normal
motor development of a young child (18),
these batteries have been used to assess
motor deficiencies in children, typically in
children with developmental disorder, or
intellectual disability, but have almost no
use in adults. The Bruininks motor abil-
ity test (BMAT), an adult adaptation of the
BOT-2, has recently been developed, but to
our knowledge has never been investigated
in adult psychiatric patient samples. Nev-
ertheless, such an instrument with a focus
on broad motor functioning is more sensi-
tive to quantitative deficits, but in its turn
lacks the capacity to assess more specific
qualitative deficits.
Therefore, in order to have a more
complete assessment of motor deficits in
schizophrenia patients (as well as patients
with other psychiatric illnesses), a test bat-
tery that encompasses on one hand tests
assessing the different motor functions
quantitatively and on the other assess-
ments addressing qualitative deficits is
needed. A consensus on which qualita-
tive deficits should be included and on
which assessment techniques to use in
such a battery will contribute to a uni-
formed and more complete assessment of
motor functioning in psychiatric illnesses.
A large study in different psychiatric pop-
ulations would consequently be needed
to further validate this new motor test
battery.
Chen and colleagues (22) developed
a comprehensive neurological evaluation
scale, the Cambridge Neurological Inven-
tory, which addresses many of the motor
functions on both a quantitative and qual-
itative level. This interesting tool assesses
different domains of motor function-
ing, and constitutes of three subscales:
(1) Speech, eye movements, and extrem-
ity examinations, (2) Soft signs exami-
nations, and (3) assessments of posture
and movements, including catatonia and
tardive dyskinesia. Sadly, after its intro-
duction, this instrument has mostly been
used for its soft signs subscale (23, 24)
whereas the total scale seems to have sunk
into oblivion. This scale may prove to be
a good starting point to further devel-
opment of the proposed wide-ranging
motor test battery. In addition, the battery
should make use of instrumental assess-
ment techniques.
Given that (psycho)motor deficits have
been observed in neuroleptic-naïve first-
episode patients, in stabilized young
patients and in chronic patients, the use
of this battery would be relevant in all
phases of the illness (1, 9, 13). Such a
battery may be used to further investigate
the neurobiological underpinnings of these
deficits, as well as to differentiate intrin-
sic motor deficits from the antipsychotic-
induced motor side effects.
CONCLUSION
A wide range of motor abnormali-
ties can be observed in schizophrenia
patients and their high prevalence war-
rant recognition of this motor symp-
tom cluster. However, predefined motor
syndromes such as catatonia are ham-
pered by many limitations, and a more
holistic approach may be needed to fur-
ther our understanding of the motor
syndrome. Research focused on assess-
ing a wide range of motor functions
encompassing both basic motor skills and
higher order psychomotor functions is
needed. The development of a motor
test battery that will both quantify the
main motor functions and assess qual-
itative deficits may contribute to new
insights in motor functioning of psychi-
atric patients including those suffering
from schizophrenia.
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